Health Startup Noom Adding GLP-1 Drugs to Med Plan Now
Noom is shifting from psychology-based weight loss to prescription treatments, launching Noom Med in a multi-state ro...
Why Active Funds May Underperform Benchmarks discusses persistent headwinds, costs, and timing issues that hinder outperformance.
26,804 articlesNoom is shifting from psychology-based weight loss to prescription treatments, launching Noom Med in a multi-state ro...
Major restaurant chains are testing smaller portions as inflation and weight-management trends push diners toward val...
As market volatility persists in March 2026, traders are eyeing best stocks under $10 for potential gains. The group ...
A colossal AI infrastructure agreement links Meta Platforms with Nebius in a five-year plan worth $27 billion. This a...
The federal debt surpassed $39 trillion this week, marking a watershed moment for Americans’ finances and national st...
Regulators delivered a clearer token framework that moves most digital assets out of presumptive securities. But the ...
Hybrids now make up about 20% of U.S. vehicle sales in Q4 2025, signaling a major shift in consumer buying and the tr...
Microsoft stock slid about 25% in Q1 2026, its worst showing in years, as AI spending accelerates yet revenue signals...
Palantir delivered an 85% year-over-year revenue surge in Q1 2026 and lifted full-year targets, but the shares are do...
Match Group revived a shuttered internship, drawing tens of thousands of applicants for a handful of slots, underscor...
A wave of budget-conscious shoppers is steering growth at discount grocers, reshaping grocery traffic and profits. An...
A growing number of newlyweds confront the mine-vs.-ours debt question as one partner considers wiping out the $28,00...